Preclinical Evaluation Of Neutralizing Antibodies Elicit
$0Z01FY2002AINIH
Niaid Extramural Activities
Investigators
Linked publications & trials
Paper 19264769Paper 19004960Paper 18833294Paper 18155743Paper 18052607Paper 17599382Paper 17360741Paper 17113201Paper 16690178Paper 16616287Paper 16460776Paper 16415019Paper 16194587Paper 16051804Paper 16051803Paper 16005039Paper 15837367Paper 15613305Paper 15582651Paper 15113908Paper 15047819Paper 14963135Paper 11967298
Abstract
The ability to make accurate and precise measurements of antibody-mediated virus neutralization is important for the evaluation of mechanisms of neutralization and for the assessment of antibody responses elicited by immunization. For HIV-1, the use of primary virus isolates and human target cells, such as PBMC, is an in vitro assay system that is believed to measure physiologically relevant virus neutralization. Using this assay, preclinical antibody responses generated by vaccine candidates were screened and measured.
View original record on NIH RePORTER →